CH618015A5 - - Google Patents

Download PDF

Info

Publication number
CH618015A5
CH618015A5 CH161277A CH161277A CH618015A5 CH 618015 A5 CH618015 A5 CH 618015A5 CH 161277 A CH161277 A CH 161277A CH 161277 A CH161277 A CH 161277A CH 618015 A5 CH618015 A5 CH 618015A5
Authority
CH
Switzerland
Prior art keywords
reagent
camp
cgmp
solution
reagents
Prior art date
Application number
CH161277A
Other languages
English (en)
French (fr)
Inventor
Omokazu Satoh
Junichi Takezawa
Akira Kuninaka
Miyuki Honma
Michio Ui
Original Assignee
Yamasa Shoyu Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamasa Shoyu Kk filed Critical Yamasa Shoyu Kk
Publication of CH618015A5 publication Critical patent/CH618015A5/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/826—Additives, e.g. buffers, diluents, preservatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CH161277A 1976-02-12 1977-02-10 CH618015A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51014665A JPS5825980B2 (ja) 1976-02-12 1976-02-12 サイクリックヌクレオチドの定量法

Publications (1)

Publication Number Publication Date
CH618015A5 true CH618015A5 (de) 1980-06-30

Family

ID=11867499

Family Applications (1)

Application Number Title Priority Date Filing Date
CH161277A CH618015A5 (de) 1976-02-12 1977-02-10

Country Status (7)

Country Link
US (1) US4115538A (de)
JP (1) JPS5825980B2 (de)
CA (1) CA1092022A (de)
CH (1) CH618015A5 (de)
DE (1) DE2705897C3 (de)
FR (1) FR2341139A1 (de)
GB (1) GB1527465A (de)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4378344A (en) * 1979-09-28 1983-03-29 Ventrex Laboratories, Inc. Method and apparatus for performing multiple, simultaneous in vitro diagnostic tests using a solid phase system
US4433061A (en) * 1981-06-01 1984-02-21 American Hospital Supply Corporation Radioimmunoassay for cyclic nucleotides
JPS5811857A (ja) * 1981-07-15 1983-01-22 Yamasa Shoyu Co Ltd アデノシンの定量法
US5118607A (en) * 1989-10-23 1992-06-02 Hawaii Biotechnology Group, Inc. Non-aqueous solvent specific binding protein assays
CA2238283C (en) * 1997-05-30 2002-08-20 Cell Pathways, Inc. Method for identifying compounds for inhibition of neoplastic lesions, pharmaceutical compositions from such compounds and uses of such compounds and compositions for treating neoplastic lesions
US7402400B2 (en) 2001-07-03 2008-07-22 Regents Of The University Of California Mammalian sweet taste receptors
US6686171B2 (en) 1999-05-10 2004-02-03 Tropix, Inc. Competitive chemiluminescent assay for cyclic nucleotide monophosphates
US6794156B2 (en) 1999-05-10 2004-09-21 Applera Corporation Cell growth, induction and lysis in an antibody-coated microplate for use in an ELISA
TW201006846A (en) 2000-03-07 2010-02-16 Senomyx Inc T1R taste receptor and genes encidung same
TW201022287A (en) 2001-01-03 2010-06-16 Senomyx Inc T1R taste receptors and genes encoding same
US7883856B2 (en) 2001-04-05 2011-02-08 Senomyx Inc. Identification of bitter ligands that specifically activate human T2R receptors and related assays for identifying human bitter taste modulators
US7803982B2 (en) 2001-04-20 2010-09-28 The Mount Sinai School Of Medicine Of New York University T1R3 transgenic animals, cells and related methods
IL158488A0 (en) * 2001-04-20 2004-05-12 Sinai School Medicine Tir3 a novel taste receptor
US6809104B2 (en) * 2001-05-04 2004-10-26 Tularik Inc. Fused heterocyclic compounds
US20070135425A1 (en) * 2001-05-04 2007-06-14 Amgen Inc. Fused heterocyclic compounds
EP2003451B1 (de) 2001-06-26 2012-05-30 Senomyx, Inc. Heterooligomere t1r1-t1r3 Umamigeschmacksrezeptoren und diese exprimierende Zellinien sowie Verwendung davon zur Identifizierung von Umamigeschmacksverbindungen
JP2005522187A (ja) * 2001-10-12 2005-07-28 ザ レジェンツ オブ ザ ユニバーシティー オブ カリフォルニア サン ディエゴ 胃腸化学感覚受容体
EP1562943A1 (de) * 2002-11-06 2005-08-17 Amgen Inc. Kondenzierte heterozylkische verbindungen
CA2900181C (en) 2003-08-06 2019-01-29 Catherine Tachdjian Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
US20050244810A1 (en) * 2003-09-29 2005-11-03 Egan Josephine M Taste signaling in gastrointestinal cells
JP5342878B2 (ja) 2005-10-20 2013-11-13 セノミクス・インコーポレーテッド キメラヒト甘味‐旨味および旨味‐甘味味覚受容体
US20110097741A1 (en) * 2006-04-20 2011-04-28 Jay Patrick Slack Partial t1r2 nucleic acid sequence, receptor protein and its use in screening assays
EP2008095A1 (de) * 2006-04-20 2008-12-31 Givaudan SA Funktionelles verfahren zur identifizierung von geschmacksstoffen
WO2007121604A2 (en) 2006-04-20 2007-11-01 Givaudan Sa Method relating to sweetness enhancement
US8148536B2 (en) 2006-04-21 2012-04-03 Senomyx, Inc. Comestible compositions comprising high potency savory flavorants, and processes for producing them
WO2008086634A2 (en) * 2007-01-18 2008-07-24 Givaudan Sa Chimeric umami taste receptor, nucleic acid encoding it and use thereof
US8187822B2 (en) 2007-03-30 2012-05-29 Givaudan S.A. Methods to identify modulators
EP2187902B1 (de) 2007-08-01 2013-04-17 The General Hospital Corporation Screeningverfahren mit g-protein-gekoppelten rezeptoren und entsprechende zusammensetzungen
CA2696995C (en) 2007-08-21 2017-11-21 Senomyx, Inc. Identification of human t2r receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in compositions and use thereof
WO2010037001A2 (en) 2008-09-26 2010-04-01 Immune Disease Institute, Inc. Selective oxidation of 5-methylcytosine by tet-family proteins
EP2376101B1 (de) * 2008-12-29 2015-12-02 Trevena, Inc. Beta-arrestin-effektoren und zusammensetzungen und anwendungsverfahren dafür
US9901551B2 (en) 2009-04-20 2018-02-27 Ambra Bioscience Llc Chemosensory receptor ligand-based therapies
US8828953B2 (en) * 2009-04-20 2014-09-09 NaZura BioHealth, Inc. Chemosensory receptor ligand-based therapies
AU2010239311B2 (en) 2009-04-20 2014-05-22 Elcelyx Therapeutics, Inc. Chemosensory receptor ligand-based therapies
EP2567229A1 (de) 2010-05-07 2013-03-13 Givaudan SA Verfahren zur identifizierung von modulatoren
SG184962A1 (en) 2010-05-07 2012-11-29 Givaudan Sa Methods to identify modulators of tas2r4s receptors
EP2630491A4 (de) 2010-10-19 2014-08-27 Elcelyx Therapeutics Inc Auf chemosensorischen rezeptorliganden basierende therapien
US20120177730A1 (en) 2011-01-07 2012-07-12 Elcelyx Therapeutics, Inc. Chemosensory Receptor Ligand-Based Therapies
SI2688403T1 (sl) 2011-03-23 2017-08-31 Trevena, Inc. Ligandi opioidnih receptorjev in metode uporabe in izdelave istega
US9128079B2 (en) 2011-08-08 2015-09-08 The Coca-Cola Company Methods of using lung or bronchial epithelial cells to identify bitter taste modulators
WO2013022947A1 (en) 2011-08-08 2013-02-14 The Coca-Cola Company Cell lines comprising endogenous taste receptors and their uses
CN104168907A (zh) 2012-01-31 2014-11-26 特维娜有限公司 β-抑制蛋白效应器及其组合物与使用方法
WO2013158928A2 (en) 2012-04-18 2013-10-24 Elcelyx Therapeutics, Inc. Chemosensory receptor ligand-based therapies
NZ710444A (en) 2013-02-11 2020-08-28 Univ California Compositions and methods for treating neurodegenerative diseases and cardiomyopathy
BR112015023737A2 (pt) 2013-03-15 2017-10-24 Applied Food Biotech Inc polipeptídeo do receptor felino tas2r isolado (ftas2r), composição, polinucleotídeo isolado, par de iniciadores, vetor de expressão, célula hospedeira, cultura celular, oligonucleotídeo, anticorpo isolado ou um fragmento desse, método para identificar um composto que interage com um polipeptídeo do receptor felino tas2r, método para identificar um composto que modula um polipeptídeo do receptor felino tas2r, método para preparar uma composição comestível, método para formular uma composição comestível com palatabilidade intensificada, método para administrar um composto amargo a um animal que necessita desse, método para preparar uma composição comestível para controlar a palatabilidade da composição comestível para um animal, método para produzir uma composição de sabor para revestimento ou incorporação em uma composição comestível a ser administrada para um animal, e composição de sabor para revestimento ou incorporação em uma composição comestível a ser administrada para um animal
JP2017506235A (ja) 2014-02-07 2017-03-02 トレベナ・インコーポレイテッドＴｒｅｖｅｎａ， Ｉｎｃ． ベータ−アレスチンエフェクターの結晶性および非晶質形態
WO2015123365A1 (en) 2014-02-11 2015-08-20 Mitokinin Llc Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease
AU2015264367A1 (en) 2014-05-19 2016-12-15 Trevena, Inc. Synthesis of Beta-Arrestin Effectors
CA3015702A1 (en) 2015-09-02 2017-03-09 Trevena, Inc. 6-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
CN108366997A (zh) 2015-12-14 2018-08-03 特维娜有限公司 治疗痛觉过敏的方法
WO2018045369A1 (en) * 2016-09-05 2018-03-08 BellBrook Labs High-throughput screening assay
CA3052479A1 (en) 2017-02-17 2018-08-23 Trevena, Inc. 7-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
CN110520129A (zh) 2017-02-17 2019-11-29 特维娜有限公司 含有5元氮杂杂环的δ阿片受体调节化合物及其使用和制备方法
WO2018237145A1 (en) 2017-06-21 2018-12-27 Mitokinin, Inc. COMPOSITIONS AND METHODS USING THEM FOR THE TREATMENT OF NEURODEGENERATIVE AND MITOCHONDRIAL DISEASE
CN112858504A (zh) * 2021-01-08 2021-05-28 苏州国辰生物科技股份有限公司 一种液质联用测定生物体液样品中cGMP浓度的检测方法
WO2023154597A1 (en) 2022-02-11 2023-08-17 Firmenich Incorporated Cells expressing umami taste receptors and uses thereof

Also Published As

Publication number Publication date
DE2705897A1 (de) 1977-08-18
US4115538A (en) 1978-09-19
CA1092022A (en) 1980-12-23
FR2341139A1 (fr) 1977-09-09
DE2705897C3 (de) 1980-02-28
DE2705897B2 (de) 1979-06-21
GB1527465A (en) 1978-10-04
JPS52117418A (en) 1977-10-01
JPS5825980B2 (ja) 1983-05-31
FR2341139B1 (de) 1979-10-05

Similar Documents

Publication Publication Date Title
CH618015A5 (de)
Dixon Measurement of antibodies to insulin in serum
EP3394622B1 (de) Reagenzverdünnungsmittel
WO2015040319A1 (fr) Solution de dissociation de la vitamine d de sa protéine de liaison, procédé de détection associé et utilisation
Samanidou et al. Development of a validated HPLC method for the determination of four penicillin antibiotics in pharmaceuticals and human biological fluids
FR2500009A1 (fr) Procede et systeme de necessaire experimental diagnostique pour determiner quantitativement la presence de la forme isoenzymatique mb de la creatine kinase
FR2678387A1 (fr) Procede de dosage immuno-enzymatique de la vitamine b12 et de preparation d'un echantillon pour ce dosage.
Niemelä Acetaldehyde adducts in circulation
CH644455A5 (fr) Procede d'analyse quantitative des nucleotides cycliques et ensemble de reactifs pour la mise en oeuvre de ce procede.
FR2476320A1 (fr) Nouveau reactif immunologique pour la detection en tubes du facteur rhumatoide dans un echantillon biologique et procede de preparation de ce nouveau reactif
FR2511155A1 (fr) Detection d'anticorps auto-bloquant
FR2763691A1 (fr) Procede ameliore d'analyse immunologique par polarisation de fluorescence
WO1999040442A1 (fr) Dosage des troponines sans interferences dues a l'heparine
EP2005181B1 (de) C4d/c4b-standard für die quantitative durchflusszytometrie humoraler transplantatabstossung
Murabayashi et al. Urinary dopamine, noradrenaline and adrenaline in type 2 diabetic patients with and without nephropathy
FR2537723A1 (fr) Procede et composition pour evaluer la reaction phagocytaire
JP4163056B2 (ja) 血中インスリン濃度測定用添加剤組成物及びそれを含む採血管
EP3080144B1 (de) Stabilisierung von glutamat-dehydrogenase in einer wässrigen lösung
JP3663781B2 (ja) 安定化方法
SU1719974A1 (ru) Способ определени тиопентала натри в крови
FR2510760A1 (fr) Dosage de folates par fixation competitive de proteines perfectionne et jeu de reactifs pour sa mise en oeuvre
Handayani NOVEL METHOD THYROID HORMONE MEASUREMENT
WO2002068961A1 (fr) Reactif destine au despitage ante-mortem d"atnc
CN111443201A (zh) 一种阿司匹林耐药性检测试剂盒
CA3068908A1 (fr) Methodes d'analyse de la derive metabolique chez un sujet

Legal Events

Date Code Title Description
PL Patent ceased